Stock Comparison

ARWR vs VRTX

Arrowhead Pharmaceuticals Inc and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

ARWR

Arrowhead Pharmaceuticals Inc

Healthcare

VRTX

Vertex Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$12.00B

$123.94B

P/E (TTM)

—

28.5

Forward P/E

107.7

25.7

Price/Sales

17.9

9.9

Price/Book

25.8

6.1

EV/EBITDA

27.0

23.2

Dividend Yield

—

Profitability

Net Margin

-47.79%

35.40%

Operating Margin

-33.82%

38.97%

Return on Equity

-55.20%

23.50%

Return on Assets

-8.10%

11.90%

Growth (YoY)

Revenue Growth

171.00%

12.50%

Earnings Growth

9.80%

8.00%

Price & Risk

Beta

1.3

0.3

52-Week High

$89.59

$529.65

52-Week Low

$18.78

$376.62

Analyst Target

$110.18

$559.28

Compare ARWR and VRTX your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.